(NASDAQ: PSNL) Personalis's forecast annual revenue growth rate of 30.62% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.9%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.78%.
Personalis's revenue in 2026 is $69,669,000.On average, 9 Wall Street analysts forecast PSNL's revenue for 2026 to be $8,596,748,897, with the lowest PSNL revenue forecast at $8,195,181,378, and the highest PSNL revenue forecast at $8,870,263,369. On average, 9 Wall Street analysts forecast PSNL's revenue for 2027 to be $11,908,185,728, with the lowest PSNL revenue forecast at $10,372,189,969, and the highest PSNL revenue forecast at $13,244,252,127.
In 2028, PSNL is forecast to generate $16,991,859,635 in revenue, with the lowest revenue forecast at $14,831,298,225 and the highest revenue forecast at $18,929,209,313.